Clinical Trial Update: Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nemonoxacin to levofloxacin in adults with community-acquired pneumonia has completed and results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Pneumonia Bacterial

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Nemonoxacin (Nemonoxacin)

Snippet

Sponsor: R-Pharm | Conditions: Pneumonia, Bacterial | Phase 3 | Status: COMPLETED | Results posted: 2023-02-16